Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Mereo Biopharma Group Plc ADR (MREO)

Mereo Biopharma Group Plc ADR (MREO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Mereo Biopharma Group Plc ADR ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF GBR

www.mereobiopharma.com P: 44-33-3023-7300

Description:

Mereo BioPharma Group PLC is a biopharmaceutical company. It is focused on development and commercialization of therapeutics for patients with rare diseases. The company's product pipeline includes BPS-804, MPH-966, BCT-197, BGS-649, Navicixizumab and Etigilimab which are in clinical stage. Mereo BioPharma Group PLC is based in London, United Kingdom.

Key Statistics

Overview:

Market Capitalization, $K 347,461
Enterprise Value, $K 290,041
Shares Outstanding, K 124,986
Annual Sales, $ 10,000 K
Annual Net Income, $ -29,470 K
EBIT, $ 0 K
EBITDA, $ -27,850 K
60-Month Beta 0.85
% of Insider Shareholders 3.00%
% of Institutional Shareholders 62.83%
Float, K 121,236
% Float 97.00%
Short Volume Ratio 0.61

Growth:

1-Year Return 150.89%
3-Year Return -20.85%
5-Year Return -44.36%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 03/26/24
Earnings Per Share ttm 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

MREO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 111.60
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -294.70%
Debt/Equity 0.00
Price/Sales 34.75
Price/Cash Flow N/A
Price/Book 6.90
Book Value/Share 0.40
Interest Coverage -9.42
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar